Severe Contrast-Induced Nephropathy Leading to Dialysis Occurring in a Patient with Near-Normal Baseline Creatinine Undergoing CT Angiography Using Intravenous Contrast Only
Name:
Severe contrast-induced nephropathy ...
Size:
125.2Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Movahed, Mohammad RezaAffiliation
Department of Medicine, University of Arizona, PhoenixSarver Heart Center, Department of Medicine, University of Arizona
Issue Date
2022-01-17Keywords
contrast mediaContrast-Induced Nephropathy
coronary angiography
DIALYSIS
intra-arterial contrast exposure
intravenous contrast
Metadata
Show full item recordPublisher
Thieme Medical Publishers, Inc.Citation
Movahed, M. R. (2022). Severe Contrast-Induced Nephropathy Leading to Dialysis Occurring in a Patient with Near-Normal Baseline Creatinine Undergoing CT Angiography Using Intravenous Contrast Only. International Journal of Angiology.Rights
© 2022. International College of Angiology.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Contrast-induced nephropathy can be a major health issue in patients undergoing iodinated contrast exposure. Recently a published paper misleadingly suggested that intravenous administration of iodinated contrast is not a significant cause of contrast-induced nephropathy. This contrasts with previous studies and clinical observations of numerous contrast-induced nephropathy cases occurring in the setting of intravenous contrast exposure. A severe cause of contrast-induced nephropathy is presented occurring in a patient with near-normal creatinine receiving intravenous contrast only leading to dialysis and near death.Note
12 month embargo; first published 17 January 2022ISSN
1061-1711PubMed ID
37927840Version
Final accepted manuscriptae974a485f413a2113503eed53cd6c53
10.1055/s-0041-1741471
Scopus Count
Collections
Related articles
- [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
- Authors: Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, van Ommen V, Wildberger JE
- Issue date: 2018
- Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
- Authors: Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE
- Issue date: 2017 Apr 1
- Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
- Authors: Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW, CONTRAST Investigators
- Issue date: 2003 Nov 5
- Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
- Authors: Tong GE, Kumar S, Chong KC, Shah N, Wong MJ, Zimmet JM, Wang ZJ, Yee J, Fu Y, Yeh BM
- Issue date: 2016 Jan
- Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
- Authors: Manske CL, Sprafka JM, Strony JT, Wang Y
- Issue date: 1990 Nov
